Tumor-selective Combination Therapy

Joseph S Bair; Xiuquan Luo; David A Boothman; Xiumei Huang; Xinpeng Ma; Paul J Hergenrother; Jinming Gao; Zachary Moore; Elizabeth I Parkinson; Lifen Cao

Tumor-selective Combination Therapy

Joseph S Bair (Inventor), Xiuquan Luo (Inventor), David A Boothman (Inventor), Xiumei Huang (Inventor), Xinpeng Ma (Inventor), Paul J Hergenrother (Inventor), Jinming Gao (Inventor), Zachary Moore (Inventor), Elizabeth I Parkinson (Inventor), Lifen Cao (Inventor)

Research output: Patent

Abstract

The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective legality is beneficial in chemotherapeutic therapy, particularly where the disease is accompanied by elevated levels of NQO1.

Original language	English (US)
U.S. patent number	10576096
State	Published - Mar 3 2020

Library availability

Discover UIUC Full Text

Cite this

@misc{0bf48ba2b45345c4954d3bbd87117c1c,

title = "Tumor-selective Combination Therapy",

abstract = "The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective legality is beneficial in chemotherapeutic therapy, particularly where the disease is accompanied by elevated levels of NQO1.",

author = "Bair, {Joseph S} and Xiuquan Luo and Boothman, {David A} and Xiumei Huang and Xinpeng Ma and Hergenrother, {Paul J} and Jinming Gao and Zachary Moore and Parkinson, {Elizabeth I} and Lifen Cao",

year = "2020",

month = mar,

day = "3",

language = "English (US)",

type = "Patent",

note = "10576096",

}

TY - PAT

T1 - Tumor-selective Combination Therapy

AU - Bair, Joseph S

AU - Luo, Xiuquan

AU - Boothman, David A

AU - Huang, Xiumei

AU - Ma, Xinpeng

AU - Hergenrother, Paul J

AU - Gao, Jinming

AU - Moore, Zachary

AU - Parkinson, Elizabeth I

AU - Cao, Lifen

PY - 2020/3/3

Y1 - 2020/3/3

N2 - The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective legality is beneficial in chemotherapeutic therapy, particularly where the disease is accompanied by elevated levels of NQO1.

AB - The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective legality is beneficial in chemotherapeutic therapy, particularly where the disease is accompanied by elevated levels of NQO1.

M3 - Patent

M1 - 10576096

ER -

Tumor-selective Combination Therapy

Abstract

Library availability

Fingerprint

Cite this